There Are a Few Times When Covered Entities CEs Can Use and Disclose Protected Health Information PHI Without Permission From the Person: One Example Is When __

One example is when a covered entity uses or discloses protected health information for treatment, payment, or health care operations. These three activities form the "TPO" exception at the core of the HIPAA Privacy Rule, and they cover most routine uses of PHI in American health care. No patient authorization is required for them. The rule instead requires that the covered entity have provided a Notice of Privacy Practices and that the use fit within defined boundaries.

This explainer goes deeper than a list of exceptions. It explains the legal architecture, the mechanisms that decide which uses need permission, the edge cases that trip up compliance officers, and the practical steps a privacy officer can take to keep routine disclosures inside the safe harbor.

How the permission architecture works

The HIPAA Privacy Rule, issued by the Department of Health and Human Services under the authority of the Health Insurance Portability and Accountability Act of 1996, starts from a simple default. A covered entity may not use or disclose PHI except as the rule permits or as the individual authorizes in writing. The exception list is long, but the exceptions are not equally weighted. TPO is the broadest and the most frequently invoked.

The mechanism is a two-layer test. First, the entity must be a covered entity: a health plan, a health care clearinghouse, or a health care provider that transmits health information electronically in connection with a standard transaction. Second, the use or disclosure must map onto a permitted category. Treatment means providing, coordinating, or managing care, including consultations between providers. Payment means activities such as claims, eligibility checks, and utilization review. Health care operations means quality assessment, training, business planning, and certain compliance activities.

The distinction matters because the rule grants permission to the entity, not to the individual employee. A hospital may disclose PHI for treatment, but the disclosure must still be limited to the minimum necessary information for that purpose, with an exception for treatment disclosures among providers. The minimum necessary standard is the main operational limit on the TPO exception.

A counterintuitive detail: the Privacy Rule does not require a signed authorization for most disclosures a patient would find surprising, including some public health reporting. Conversely, it does require an authorization for many disclosures a patient might assume are routine, such as marketing that involves remuneration. The exception list reflects policy choices about which social goods justify bypassing individual permission.

Quantified context: how large the TPO channel is

TPO is not a niche pathway. It is the main channel through which PHI moves in the American health system. Every insurance claim, every referral, every quality audit, and every hospital accreditation review depends on it. The Department of Health and Human Services has stated that the Privacy Rule is designed to permit these routine activities while protecting the confidentiality of the underlying records.

The scale can be inferred from the structure of the exception. The rule permits disclosure for treatment, payment, and operations without a per-disclosure authorization, which means the count of permitted disclosures is effectively the count of claims, referrals, and internal quality activities. No published federal figure isolates that count, and none should be invented. What can be said with confidence is that the exception is broad by design and that most PHI flows fall inside it.

Time matters in a different sense. The rule became effective in 2003, and it has been amended several times, including through the HITECH Act of 2009 and the 2024 reproductive health privacy rule. Those amendments have narrowed specific pathways, such as disclosures for certain reproductive health purposes, while leaving the TPO backbone intact. A compliance program built on a 2003 reading of the rule may therefore be out of date.

The minimum necessary standard applies to most payment and operations disclosures but not to treatment disclosures among providers. That asymmetry explains why a primary care physician can send a full chart to a specialist without stripping fields, while a billing office should request only the data elements needed to adjudicate a claim. The asymmetry is a design feature, not an oversight.

Edge cases where permission questions get hard

The hardest cases cluster around the boundary between TPO and other exceptions. A hospital that shares PHI with a business associate is not relying on the TPO exception alone; it must have a business associate agreement in place. A provider that discloses PHI to a family member involved in the patient's care may rely on the involvement exception, which requires the patient to be present or incapacitated and the disclosure to be in the patient's best interest. Mixing these pathways without the right paperwork is a common compliance failure.

Public health reporting is another edge case. The rule permits disclosures to public health authorities for activities such as disease surveillance and reporting of adverse events to the FDA, but the scope is defined by federal and state law. A provider cannot expand the exception by convenience. The law that authorizes the reporting also sets its limits.

Research is a separate pathway with its own conditions, including institutional review board approval or a waiver, and it is not part of TPO. A covered entity that treats research as operations risks a violation. The same is true of fundraising, which has a specific exception with opt-out requirements, and of marketing, which generally requires authorization.

A professional caveat: the minimum necessary standard is not a floor. It is a ceiling that requires a documented determination of what is reasonably necessary for the stated purpose. Entities that skip documentation often pass audits but fail enforcement actions, because the standard is about the process as much as the outcome.

Disclosing more than the minimum necessary for payment without documenting the determination. Treating a business associate disclosure as covered by TPO without a signed business associate agreement. Relying on the involvement exception when the patient has capacity and objects. Expanding a public health disclosure beyond what the authorizing law permits. Treating research or fundraising as health care operations without the specific conditions. Using a 2003-era policy after later amendments narrowed the relevant pathway.

Common misconceptions

The most common misconception is that every disclosure of PHI requires a signed authorization. The Privacy Rule does not work that way. It requires permission only when no exception applies. TPO is the largest exception, but public health, law enforcement, judicial proceedings, and certain other categories also operate without patient authorization.

A second misconception is that the patient owns the record and can veto any use. Ownership of the physical or electronic record usually rests with the provider, and the rule grants rights of access and amendment rather than a general veto. The patient can restrict certain disclosures, such as those to a health plan for services paid out of pocket, but the general rule is permission by default through exceptions.

A third misconception is that de-identified data is PHI. It is not. The rule defines two de-identification methods, the safe harbor of removing 18 specified identifiers and expert determination, and properly de-identified data falls outside the rule. Entities that treat de-identified data as PHI waste resources; entities that de-identify improperly create a violation.

A fourth misconception concerns the role of state law. HIPAA sets a floor, not a ceiling. State laws that are more protective, such as stricter consent rules for certain sensitive categories, continue to apply. A covered entity must satisfy both. This is why a disclosure that is permitted under HIPAA may still be barred under state law.

Practical actions for compliance teams

A privacy officer can reduce risk by building the program around the exception categories rather than around individual disclosures. The first step is a current inventory of every routine PHI flow and the exception that authorizes it. Flows that do not map cleanly are candidates for an authorization or a business associate agreement.

The second step is a minimum necessary determination for each payment and operations flow. Document the purpose, the data elements required, and the person who made the determination. Review the determination annually and after any rule change.

The third step is training that distinguishes TPO from research, fundraising, and marketing. Staff who assume all internal sharing is operations are the most likely source of violations. A short decision tree at the point of disclosure is more effective than an annual slide deck.

The fourth step is a state-law overlay. Map the states in which the entity operates and identify stricter consent rules for sensitive categories, including reproductive health, substance use, and mental health. The 2024 reproductive health rule and the longstanding confidentiality rules for substance use disorder records are the clearest examples of where federal permission does not equal state permission.

The fifth step is an audit cadence. Sample disclosures quarterly, check for the business associate agreement, the minimum necessary determination, and the correct exception. Track exceptions to the exception, meaning disclosures that required an authorization but were made under TPO, because those are the highest-risk findings.

Thresholds worth reconciling explicitly: the minimum necessary standard applies to payment and operations but not to treatment disclosures among providers; the involvement exception requires the patient to be present or incapacitated; and the authorization requirement applies to marketing with remuneration but not to most public health reporting. These thresholds do not conflict, but they are frequently conflated in policy manuals.

Limitations and what the rule cannot promise

The TPO exception is broad, but it is not a general license to share PHI. It is bounded by the minimum necessary standard, by the Notice of Privacy Practices, and by state law. It also depends on accurate classification of the activity. A disclosure labeled as operations that is really marketing is a violation regardless of intent.

Enforcement has changed the practical meaning of the rule. The Office for Civil Rights has pursued settlements involving minimum necessary failures and business associate agreement gaps, and the HITECH Act raised the stakes with tiered penalties. The exception structure has not changed in kind, but the cost of misclassification has risen.

The rule also cannot resolve every conflict. Where federal permission and state restriction collide, the entity must satisfy the stricter rule. Where the patient objects to an involvement disclosure and has capacity, the involvement exception does not apply. Where the authorizing law for a public health report is ambiguous, the safer course is to seek legal review before disclosing.

This article is general educational information about the HIPAA Privacy Rule, not a legal opinion or a compliance determination for any specific entity. Covered entities should consult qualified counsel and their privacy officers before relying on any exception for a particular disclosure.